Targeted Therapy and Molecular Diagnostics

Targeted Therapy and Molecular Diagnostics involve the use of specific drugs or treatments that target the molecular and genetic changes driving cancer growth, rather than affecting all rapidly dividing cells like traditional chemotherapy. Molecular diagnostics play a key role by analyzing genetic mutations, proteins, and other biomarkers in tumors to identify these specific targets. This allows for the development of targeted therapies that focus on blocking or modifying the action of cancer-causing molecules, improving treatment efficacy and reducing side effects. These approaches enable more personalized, precise cancer treatments that are tailored to the individual characteristics of a patient's tumor, leading to better outcomes.

    Related Conference of Targeted Therapy and Molecular Diagnostics

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Targeted Therapy and Molecular Diagnostics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in